lifestyle.side.cr

Author: Microbot Medical Inc.

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

April 22, 2026
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

April 14, 2026
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

April 13, 2026
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

March 26, 2026
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

March 24, 2026
Microbot Medical® to Participate at the 38th Annual Roth Conference

March 17, 2026
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

March 10, 2026
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

March 4, 2026
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

March 3, 2026
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

February 24, 2026